Lo Re, V., Carbonari, D. M., Saine, M. E., Newcomb, C. W., Roy, J. A., Liu, Q., . . . Strom, B. L. (2017). Postauthorization safety study of the DPP-4 inhibitor saxagliptin: A large-scale multinational family of cohort studies of five outcomes. BMJ Open Diabetes Res Care.
シカゴスタイル引用形Lo Re, Vincent, et al. "Postauthorization Safety Study of the DPP-4 Inhibitor Saxagliptin: A Large-scale Multinational Family of Cohort Studies of Five Outcomes." BMJ Open Diabetes Res Care 2017.
MLA引用形式Lo Re, Vincent, et al. "Postauthorization Safety Study of the DPP-4 Inhibitor Saxagliptin: A Large-scale Multinational Family of Cohort Studies of Five Outcomes." BMJ Open Diabetes Res Care 2017.
警告: この引用は必ずしも正確ではありません.